insert name of The Institution] [insert name of the Developer] Model Fast Track Testing and Evaluation AgreementOctober 4th, 2016
FiledOctober 4th, 2016Scenario – The Institution prioritises and evaluates the Developer’s Materials against Pathogen of Interest during a ‘One Health’ crisis facing people, animals and/or the environment, and contributes to the potential development of the Materials as Product. Confidential Information excludes Results. The Institution has the right to use for academic and research purposes. The Institution can notify Global Stakeholders that they are carrying out the Work, timeline, details of the Developer, Materials, etc. The Institution has right to publish Results (including ‘poor’ or ‘negative’ results) and make them available in databases set up by Global Stakeholders. Discount if Product is sold back to the Institution or Commissioning Bodies. Originally developed at Public Health England for a Wellcome Trust-funded project to explore possible treatment options for Ebola, and subsequently for Zika.